Patent Attorney Review of Systems, devices, and methods for monitoring medical devices
U.S. Patent 9,949,642 The patent drafted by a patent attorney appears to be related to a detection and monitoring system particularly for diabetics and related glucose levels. This patent appears to check whether a diabetic’s glucose levels are within a clinically safe range. This will in turn provide information to a diabetic for determining when to raise or reduce glucose levels. The patent holder sought an “improved” analyte monitoring system, device, and method. The patent on its face appears to be owned by Abbot that has a number of Diabette products, including the freestyle libre, navigator, optium/precision neo, lite, freedome lite, and insulinx to name a few. Abbott strongly defends its intellectual property having won an appeal back in 2011 years ago for 1.67 Billion dollars. A patent infringement attorney can review the patent to determine the strength of a given case. On April 24, 2018, Week 17, Number 1449-4, the United States Patent and Trademark Office published issued U.S. Patent Number 9,949,642. The patent describes a relay device is used to provide a communication link between a medical device, such as an analyte sensor control device, and a reader device, such as a mobile communication device or smartphone. The medical device can be placed in a continuous mode in which the medical device communicates with the relay device at a predetermined periodic time interval, or in an on-demand mode in which the medical device communicates with the relay device upon actuation by the user. In some embodiments, the relay device communicates with the medical device using a near field communication (NFC) communication protocol, and with the reader device using a Bluetooth protocol. In certain embodiments, the timing of the communication between the medical device [...]